Treatment of Dawson's encephalitis wit5-bromo-2'-deoxyuridine. Double-blind study.
D000293:Adolescent; D000818:Animals; D001706:Biopsy; D001921:Brain / Q000473:pathology; D001973:Bromodeoxyuridine / Q000627:therapeutic use*; D002648:Child; D002986:Clinical Trials as Topic; D046508:Culture Techniques; D002549:Diffuse Cerebral Sclerosis of Schilder / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008459:Measles virus / Q000187:drug effects; D008854:Microscopy, Electron; D009207:Myoclonus / Q000188:drug therapy; D010554:Personality Disorders / Q000188:drug therapy; D010919:Placebos; D005719:gamma-Globulins / Q000134:cerebrospinal fluid
D010919:Placebos; D005719:gamma-Globulins; D001973:Bromodeoxyuridine